The Lymphatic System

 The lymphatic system is a network of vessels, nodes, and organs that  play crucial roles in maintaining fluid balance, absorbing fats from the  digestive system, and facilitating immune responses. Lymphatic vessels,  similar to blood vessels, transport lymph, a clear fluid containing  white blood cells, proteins, and waste products, from tissues back to  the bloodstream. Lymph nodes, scattered throughout the body along the  lymphatic vessels, filter lymph and serve as sites for immune cell  activation and surveillance. The spleen, thymus, tonsils, and lymphatic  tissue in mucous membranes also contribute to the lymphatic system's  functions. Additionally, lymphatic capillaries in the small intestine,  known as lacteals, absorb dietary fats and fat-soluble vitamins,  transporting them via lymph to the bloodstream. Overall, the lymphatic  system supports immune function by filtering out pathogens and cellular  debris, helps maintain fluid balance by returning excess tissue fluid to  circulation, and aids in nutrient absorption from the digestive tract. 

 Lymphedema: A condition characterized by swelling (edema) due to the accumulation of lymphatic fluid in tissues, typically in the arms or legs. Primary lymphedema results from congenital abnormalities in the lymphatic system, while secondary lymphedema can occur due to lymph node removal, radiation therapy, or infection.

• Lymphadenopathy: Enlargement or inflammation of lymph nodes, which can be caused by infections (e.g., bacterial, viral), immune disorders, malignancies, or systemic diseases.
• Lymphoma: A group of cancers affecting lymphocytes, a type of white blood cell, and lymphatic tissues. Lymphomas can be classified as Hodgkin lymphoma or non-Hodgkin lymphoma, depending on specific characteristics of the cancer cells.
• Filariasis: A parasitic infection transmitted by mosquitoes, resulting in lymphatic obstruction, inflammation, and swelling of the limbs or genitalia, known as elephantiasis.
• Lymphangitis: Inflammation of lymphatic vessels, usually secondary to bacterial infections, causing red streaks, pain, and swelling along the affected vessels.

 Inflammation: Chronic low-grade inflammation associated with insulin resistance and metabolic syndrome can contribute to lymphatic dysfunction, impairing lymphatic vessel integrity and function.

• Lymphatic Leakage: Metabolic abnormalities may disrupt the integrity of lymphatic vessels, leading to increased permeability and leakage of lymphatic fluid into surrounding tissues, contributing to edema and lymphedema.
• Immune Dysfunction: Insulin resistance and metabolic disturbances can impair immune function, potentially increasing susceptibility to infections that affect the lymphatic system, such as filariasis or lymphangitis.
• Secondary Lymphedema: Obesity, a common feature of metabolic syndrome, can increase the risk of secondary lymphedema by putting pressure on lymphatic vessels or impairing lymphatic flow, particularly in the lower limbs.
• Lymphoma Risk: Chronic inflammation, dysregulated immune responses, and impaired lymphatic function associated with metabolic syndrome may contribute to an increased risk of lymphoma development.

Overall, while the direct influence of metabolic abnormalities on the lymphatic system disorders may be limited, their effects on inflammation, immune function, and tissue integrity may indirectly contribute to the development or exacerbation of lymphatic disorders.

 Lymphedema may develop due to impaired lymphatic drainage caused by excess adipose tissue. 

 Diabetes can lead to lymphatic dysfunction, increasing the risk of infections and swelling in extremities. 

Chronic inflammation refers to a prolonged immune response characterized by the persistent activation of inflammatory pathways in the body. Unlike acute inflammation, which is a short-term and beneficial response to injury or infection, chronic inflammation can be harmful and contribute to the development of various diseases.

Several factors can contribute to chronic inflammation, including:

1. Persistent infections: Chronic infections with bacteria, viruses, or other pathogens can lead to ongoing immune activation and inflammation.
2. Autoimmune disorders: Conditions where the immune system mistakenly attacks healthy tissues can result in chronic inflammation and tissue damage.
3. Environmental factors: Exposure to environmental pollutants, toxins, or allergens can trigger chronic inflammation.
4. Lifestyle factors: Poor diet, lack of exercise, stress, smoking, and excessive alcohol consumption can all promote chronic inflammation.
5. Metabolic conditions: Obesity, insulin resistance, and metabolic syndrome are associated with chronic low-grade inflammation.

Chronic inflammation plays a significant role in the pathogenesis of many chronic diseases, including cardiovascular disease, diabetes, cancer, neurodegenerative diseases, and autoimmune disorders. Managing chronic inflammation often involves addressing underlying causes such as infections, autoimmune conditions, or lifestyle factors. Lifestyle modifications such as adopting a healthy diet, regular exercise, stress management, and avoiding harmful habits can help reduce chronic inflammation and lower the risk of associated diseases. Additionally, medications or other interventions may be used to control inflammation in certain conditions.

" Several lines of preclinical and clinical research have confirmed that  chronic low-grade inflammation of adipose tissue is mechanistically  linked to metabolic disease and organ tissue complications in the  overweight and obese organis".  

"This paper is an overview of the chronic low-grade inflammation in  adipose tissue, skeletal muscle, liver and endothelial cells during the  development of insulin resistance. "   

1. Gyorkos  A, Baker MH, Miutz LN, Lown DA, Jones MA, Houghton-Rahrig LD.  Carbohydrate-restricted Diet and High-intensity Interval Training  Exercise Improve Cardio-metabolic and Inflammatory Profiles in Metabolic  Syndrome: A Randomized Crossover Trial. Cureus. 11(9). doi:10.7759/cureus.5596
2. Jonasson  L, Guldbrand H, Lundberg AK, Nystrom FH. Advice to follow a  low-carbohydrate diet has a favourable impact on low-grade inflammation  in type 2 diabetes compared with advice to follow a low-fat diet. Ann  Med. 2014;46(3):182-187. doi:10.3109/07853890.2014.894286 
3. Phinney  S, Adams R, Athinarayanan S, McKenzie A, Volek J. SAT-LB125 Broad  Spectrum Effects of a Ketogenic Diet Delivered by Remote Continuous Care  on Inflammation and Immune Modulators in Type 2 Diabetes and  Prediabetes. J Endocr Soc. 2020;4(Supplement_1). doi:10.1210/jendso/bvaa046.2319  (5 year data    https://doi.org/10.2337/db22-212-OR.)
4. Monda  V, Polito R, Lovino A, et al. Short-Term Physiological Effects of a  Very Low-Calorie Ketogenic Diet: Effects on Adiponectin Levels and  Inflammatory States. International Journal of Molecular Sciences.  2020;21(9):3228. doi:10.3390/ijms21093228
5. Ciaffi, J. et al. (2023) ‘Efficacy, safety and tolerability of very low-calorie ketogenic  diet in obese women with fibromyalgia: a pilot interventional study’, Frontiers in Nutrition, 10. Available at: https://www.frontiersin.org/articles/10.3389/fnut.2023.1219321.Kim, E.R. et al. (2022) ‘Short Term Isocaloric Ketogenic Diet Modulates NLRP3  Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21’, Frontiers in Immunology, 13, p. 843520. doi:10.3389/fimmu.2022.843520.
6. Ruth  MR, Port AM, Shah M, et al. Consuming a hypocaloric high fat low  carbohydrate diet for 12 weeks lowers C-reactive protein, and raises  serum adiponectin and high density lipoprotein-cholesterol in obese  subjects. Metab Clin Exp. 2013;62(12):1779-1787. doi:10.1016/j.metabol.2013.07.006  PDF
7. Cipryan  L, Dostal T, Plews DJ, Hofmann P, Laursen PB. Adiponectin-leptin ratio  increases after a 12-week very low-carbohydrate, high-fat diet and  exercise training in healthy individuals: A non-randomized,  parallel-group study. Nutrition Research. Published online December 10, 2020. doi:10.1016/j.nutres.2020.12.012
8. Barrea, L. et al. (2022) ‘Phase angle as an easy diagnostic tool for the nutritionist in  the evaluation of inflammatory changes during the active stage of a very  low-calorie ketogenic diet’, International Journal of Obesity (2005) [Preprint]. doi:10.1038/s41366-022-01152-w.
9. Chrysohoou  C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the  Mediterranean diet attenuates inflammation and coagulation process in  healthy adults: The Attica study. Journal of the American College of  Cardiology. 2004;44(1):152-158. doi:10.1016/j.jacc.2004.03.039
10. Bonaccio  M, Pounis G, Cerletti C, Donati MB, Iacoviello L, Gaetano G de.  Mediterranean diet, dietary polyphenols and low grade inflammation:  Results from the MOLI-SANI study. British Journal of Clinical  Pharmacology. 2017;83(1):107-113. doi:10.1111/bcp.12924 
11. Rashid  T, Wilson C, Ebringer A. The Link between Ankylosing Spondylitis,  Crohn’s Disease, Klebsiella, and Starch Consumption. Journal of  Immunology Research. doi:10.1155/2013/872632
12. Ebringer  A, Wilson C. The Use of a Low Starch Diet in the Treatment of Patients  Suffering from Ankylosing Spondylitis. Clin Rheumatol. 1996;15(1):62-66.  doi:10.1007/BF03342649 ABSTRACT
13. Karimi  E, Yarizadeh H, Setayesh L, Sajjadi SF, Ghodoosi N, Mirzaei K. High  Carbohydrate Intakes May Predict More Inflammatory Status Than High Fat  Intakes in Pre-Menopause Women With Overweight or Obesity: A  Cross-Sectional Study. In Review; 2021. doi:10.21203/rs.3.rs-322285/v1
14. Phillips  MCL, Murtagh DKJ, Ziad F, Johnston SE, Moon BG. Impact of a Ketogenic  Diet on Sporadic Inclusion Body Myositis: A Case Study. Front Neurol.  2020;11. doi:10.3389/fneur.2020.582402 

Lipedema is a chronic condition characterized by abnormal and disproportionate accumulation of fat, typically in the lower body, particularly the hips, thighs, buttocks, and sometimes extending to the lower legs. Unlike obesity, lipedema fat is often resistant to diet and exercise. It primarily affects the subcutaneous fat layer and is more common in women.

The exact cause of lipedema is unknown, but hormonal factors, genetics, and inflammation are believed to play a role. Lipedema is often misdiagnosed or mistaken for obesity, lymphedema, or simple weight gain, leading to challenges in treatment and management.

Lipedema primarily affects the lymphatic system and adipose (fat) tissue. It can lead to chronic swelling, pain, bruising, and increased sensitivity in the affected areas. Over time, lipedema can impair mobility and quality of life.

Treatment for lipedema focuses on managing symptoms and improving quality of life. This may include compression therapy, manual lymphatic drainage, specialized exercise programs, and sometimes liposuction to reduce excess fat accumulation. Early diagnosis and intervention are crucial in preventing complications and improving outcomes for individuals with lipedema.

  Hyperinsulinemia, insulin resistance, and metabolic syndrome can worsen  lipedema by promoting fat accumulation, inflammation, and metabolic  dysfunction in adipose tissue. Elevated insulin levels in  hyperinsulinemia stimulate fat storage and inflammation. Insulin  resistance reduces sensitivity to insulin, exacerbating fat accumulation  and inflammation. Metabolic syndrome, including obesity and  dyslipidemia, further contributes to metabolic disturbances in lipedema.  Managing these metabolic issues through lifestyle changes may help  mitigate their impact on lipedema and improve overall health. 

1. Jeziorek, M. et al. (2023) ‘The Effect of a Low-Carbohydrate High-Fat Diet on Laboratory  Parameters in Women with Lipedema in Comparison to Overweight/Obese  Women’, Nutrients, 15(11), p. 2619. Available at: https://doi.org/10.3390/nu15112619.
2. Jeziorek,  M., Szuba, A., Kujawa, K., Regulska-Ilow, B., 2022. The Effect of a  Low-Carbohydrate, High-Fat Diet versus Moderate-Carbohydrate and Fat  Diet on Body Composition in Patients with Lipedema. DMSO 15, 2545–2561. doi.org/10.2147/DMSO.S377720
3. Keith L, Seo CA, Rowsemitt C, et al. Ketogenic Diet as a Potential Intervention for Lipedema. Medical Hypotheses. Published online November 27, 2020:110435. doi:10.1016/j.mehy.2020.110435 
4. Sørlie  V, De Soysa AK, Hyldmo ÅA, Retterstøl K, Martins C, Nymo S. Effect of a  ketogenic diet on pain and quality of life in patients with lipedema:  The LIPODIET pilot study. Obesity Science & Practice. (2021). doi:10.1002/osp4.580 PDF
5. Keith  L, Rowsemitt C, Richards LG. Lifestyle Modification Group for  Lymphedema and Obesity Results in Significant Health Outcomes. Am J Lifestyle Med. 2017;14(4):420-428. doi:10.1177/1559827617742108 ABSTRACT
6. Di Renzo, L. et al. (2023) ‘Modified Mediterranean-Ketogenic Diet and Carboxytherapy as  Personalized Therapeutic Strategies in Lipedema: A Pilot Study’, Nutrients, 15(16), p. 3654. Available at: https://doi.org/10.3390/nu15163654.
7. Cannataro, R. et al. (2021) ‘Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up’, Life, 11(12), p. 1402. doi:10.3390/life11121402.
8. Verde, L. et al. (2023) ‘Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?’, Current Obesity Reports [Preprint]. Available at: https://doi.org/10.1007/s13679-023-00536-x.
9. García-Caballero  M, Zecchin A, Souffreau J, et al. Role and therapeutic potential of  dietary ketone bodies in lymph vessel growth. Nature Metabolism. 2019;1(7):666-675. doi:10.1038/s42255-019-0087-y   ABSTRACT  (Preclinical study)

 Lymphedema is a chronic condition characterized by swelling, usually in  the arms or legs, caused by the accumulation of lymphatic fluid due to  damage or blockage in the lymphatic system. It can be primary (present  at birth or due to developmental issues) or secondary (resulting from  damage to the lymphatic system, often due to surgery, radiation therapy,  or infection). Symptoms include swelling, heaviness, limited range of  motion, and recurrent infections. Management typically involves  compression therapy, manual lymphatic drainage, exercise, skin care, and  sometimes surgery. Early detection and intervention are crucial for  effective management. 

 Insulin resistance, metabolic syndrome, and hyperinsulinemia can worsen  lymphedema by promoting inflammation, impairing lymphatic function, and  increasing fluid retention. Insulin resistance reduces cellular response  to insulin, while metabolic syndrome clusters conditions like obesity  and high blood pressure, exacerbating lymphatic dysfunction.  Hyperinsulinemia, elevated insulin levels, further contribute to tissue  damage and fluid retention. Managing these metabolic issues through  lifestyle changes can mitigate their impact on lymphedema and overall  health. 

1. Jeziorek, M. et al. (2023) ‘The Effect of a Low-Carbohydrate High-Fat Diet on Laboratory  Parameters in Women with Lipedema in Comparison to Overweight/Obese  Women’, Nutrients, 15(11), p. 2619. Available at: https://doi.org/10.3390/nu15112619.
2. Jeziorek,  M., Szuba, A., Kujawa, K., Regulska-Ilow, B., 2022. The Effect of a  Low-Carbohydrate, High-Fat Diet versus Moderate-Carbohydrate and Fat  Diet on Body Composition in Patients with Lipedema. DMSO 15, 2545–2561. doi.org/10.2147/DMSO.S377720
3. Keith L, Seo CA, Rowsemitt C, et al. Ketogenic Diet as a Potential Intervention for Lipedema. Medical Hypotheses. Published online November 27, 2020:110435. doi:10.1016/j.mehy.2020.110435 
4. Sørlie  V, De Soysa AK, Hyldmo ÅA, Retterstøl K, Martins C, Nymo S. Effect of a  ketogenic diet on pain and quality of life in patients with lipedema:  The LIPODIET pilot study. Obesity Science & Practice. (2021). doi:10.1002/osp4.580 PDF
5. Keith  L, Rowsemitt C, Richards LG. Lifestyle Modification Group for  Lymphedema and Obesity Results in Significant Health Outcomes. Am J Lifestyle Med. 2017;14(4):420-428. doi:10.1177/1559827617742108 ABSTRACT
6. Di Renzo, L. et al. (2023) ‘Modified Mediterranean-Ketogenic Diet and Carboxytherapy as  Personalized Therapeutic Strategies in Lipedema: A Pilot Study’, Nutrients, 15(16), p. 3654. Available at: https://doi.org/10.3390/nu15163654.
7. Cannataro, R. et al. (2021) ‘Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up’, Life, 11(12), p. 1402. doi:10.3390/life11121402.
8. Verde, L. et al. (2023) ‘Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?’, Current Obesity Reports [Preprint]. Available at: https://doi.org/10.1007/s13679-023-00536-x.
9. García-Caballero  M, Zecchin A, Souffreau J, et al. Role and therapeutic potential of  dietary ketone bodies in lymph vessel growth. Nature Metabolism. 2019;1(7):666-675. doi:10.1038/s42255-019-0087-y   ABSTRACT  (Preclinical study)